BioSpace News Archive

Nasus Pharma Announces Publication Of Its Positive Clinical Results With FMXIN002 Intranasal Powder Epinephrine Spray In The Journal Of Allergy And Clinical Immunology In Practice

Nasus Pharma Ltd a clinical-stage biopharmaceutical company focused on developing needle-free, powder-based Intranasal (PBI) product portfolio, to address acute medical conditions announced the publication of positive results from a clinical study of intranasal powder-based Epinephrine.

August 8, 2023
·
6 min read
Business

Rallybio Reports Second Quarter 2023 Financial Results and Provides Business Updates

Rallybio Corporation (Nasdaq: RLYB) today reported financial results for the second quarter ended June 30, 2023 and provided an update on recent program and corporate developments.

August 8, 2023
·
11 min read
Business

Processa Pharmaceuticals Appoints Life Sciences Industry Veteran George Ng as Chief Executive Officer

Processa Pharmaceuticals, Inc. announces today that industry veteran George Ng has been appointed to serve as the Company’s Chief Executive Officer and as a Board Director as of August 8, 2023.

August 8, 2023
·
6 min read
Business

Horizon Therapeutics plc Reports Second-Quarter 2023 Financial Results

Horizon Therapeutics plc Reports Second-Quarter 2023 Financial Results.

August 8, 2023
·
32 min read
Business

CorMedix Inc. Reports Second Quarter and Six Month 2023 Financial Results and Provides Business Update

CorMedix Inc. today announced financial results for the second quarter and six months ended June 30, 2023 and provided an update on recent business events.

August 8, 2023
·
9 min read
Business

Abeona Therapeutics Reports Second Quarter 2023 Financial Results

Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the second quarter of 2023 and provided an update on progress toward achieving key corporate objectives.

August 8, 2023
·
9 min read
Race Strategic Update August 2023

Race Oncology Limited is pleased to provide a strategic update, including an overview of revisions to corporate strategy, designed to optimise use of existing resources, while driving bisantrene’s commercial partnering and collaboration potential.

August 8, 2023
·
4 min read
Business

Palatin’s Vyleesi® Licensee Fosun Pharma Reports First Commercial Sale in China and South Korean Licensee Kwangdong Pharmaceuticals Completes Enrollment in Phase 3 Clinical Study

Palatin Technologies, Inc. today announced that Fosun Pharma, the licensee of Vyleesi in China, reported its first sale in the Hainan Province of China.

August 8, 2023
·
6 min read
Business

Syros Reports Second Quarter 2023 Financial Results and Provides a Corporate Update

Syros Pharmaceuticals today reported financial results for the quarter ended June 30, 2023 and provided a corporate update.

August 8, 2023
·
9 min read
Business

Agenus Reports Second Quarter 2023 Results

Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced results for the second quarter 2023.

August 8, 2023
·
10 min read